日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Innovative logic "AND" gate gene circuits for bladder cancer treatment: preclinical study.

用于膀胱癌治疗的创新逻辑“与”门基因回路:临床前研究

Xu Chaojie, Dong Ying, Pei Dongchen, Zhang Xintao, Han Xiaohong, Cao Congcong, Wu Baorui, Lv Changning, Kang Zhengjun, Zhou Liqun, Liu Yuchen, Yao Lin

Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responses

膀胱癌肿瘤微环境异质性可识别生物学上不同的亚型,这些亚型可预测预后和抗PD-L1治疗反应。

Li, YaFei; Liu, Yi; Kang, Zhengjun; Guo, Jianhua; Liu, Nan

Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer

第二原发性前列腺癌竞争风险列线图的临床特征和前列腺癌特异性死亡率

Xu, Chaojie; Pei, Dongchen; Liu, Yi; Guo, Jianhua; Liu, Nan; Wang, Qian; Yu, Yang; Kang, Zhengjun

Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation

M1巨噬细胞相关基因鉴定在膀胱尿路上皮癌中的临床价值及体外验证

Yu, Yang; Huang, Yuexi; Li, Chen; Ou, Santao; Xu, Chaojie; Kang, Zhengjun

Application of m(6)A and TME in Predicting the Prognosis and Treatment of Clear Cell Renal Cell Carcinoma

m(6)A 和 TME 在预测透明细胞肾细胞癌预后和治疗中的应用

Pei, Dongchen; Xu, Chaojie; Wang, Dong; Shi, Xiaoxue; Zhang, Yurui; Liu, Yi; Liu, Nan; Guo, Jianhua; Yu, Yang; Kang, Zhengjun; Zhu, Haipeng

CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes

CXCL12 和 CD3E 作为膀胱癌肿瘤微环境调控的指标及其与免疫浸润和分子亚型的相关性

Liu, Yi; Wu, YuCai; Zhang, PeiPei; Xu, ChaoJie; Liu, ZeSen; He, ChaoJie; Liu, YiMing; Kang, ZhengJun

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer

鉴定用于膀胱癌预后预测的六种RNA结合蛋白特征

Wu, Yucai; Liu, Yi; He, Anbang; Guan, Bao; He, Shiming; Zhang, Cuijian; Kang, Zhengjun; Gong, Yanqing; Li, Xuesong; Zhou, Liqun